Clinical Development Partnerships

Clinical Development Partnerships (CDP) is a joint initiative launched by Cancer Research UK and Cancer Research Technology Limited. CDP aims to increase the number of successful new treatments for cancer patients by taking more compounds into clinical development.

The programme is primarily targeted at leading pharmaceutical and biotechnology companies who have large pipelines and are forced to prioritise which agents they take into clinical development. Clinical trials are inherently expensive and rigorous selection criteria are applied to potential agents. As a result many promising cancer agents have been shelved and their clinical development discontinued.

CDP offers companies an alternative path for clinical development bringing new life to deprioritised cancer agents. It is a unique opportunity for companies to maximise the value of their shelved assets and work with Cancer Research UK, the largest independent organisation dedicated to cancer research in the world, to develop new agents for the benefit of cancer patients.

To view the CDP website please click here.